The landscape of dementia diagnosis has progressed radically with the arrival of innovative biomarkers, which includes amyloid PET scans, tau imaging, and blood-based checks that could detect Alzheimer's pathology many years before signs or symptoms emerge. Though these technological improvements signify extraordinary progress in being familiar with neurodegenerative conditions, they https://mannerst853sck2.mywikiparty.com/user